Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

18.09.24

Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis

PBPK & PBBM

Infectious Diseases

Clin Transl Sci. 2024; 17:e13908

Ibnou Zekri Lassout N, Goyal V, Krantz E, Simon F, Neven A, Eriksson J, Saayman A, Satam V, Ruffell C, Victor S, Chenel M, Celebic A, Caplain H, Gillon J-Y, Deshmukh A, Antarkar A, Sjögren E, Ribeiro I

16.09.24

PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space

PBPK & PBBM

Hematology

CPT Pharmacometrics Syst Pharmacol. 2024 Sep 16.

Cloesmeijer ME, Sjögren E, Koopman SF, Lenting PJ, Cnossen MH, Mathôt RAA; OPTI‐CLOT study group and SYMPHONY consortium.

27.06.24

Full random effects models (FREM): A practical usage guide

Pharmacometrics

Methodology

CPT Pharmacometrics Syst Pharmacol. 2024 Aug;13(8):1297-1308.

Jonsson EN, Nyberg J

25.06.24

A workflow for evaluating and optimizing the designs of paediatric studies

Specific populations

Pharmacometrics

PAGE 32 (2024) Abstr 11082

Ibrahim MMA, Hansson E, Hooker AC, Bergstrand M

25.06.24

Development of a PBPK model to predict monoclonal antibody pharmacokinetics and bioavailability following subcutaneous administration

PBPK & PBBM

PAGE 32 (2024) Abstr 10780

Benamara S, Teutonico D, Gattacceca F, Nguyen L, Deslandes A, Chenel M, Sjögren E

25.06.24

Physiologically-based pharmacokinetic (PBPK) modeling to predict disease effects on 5-flucytosine pharmacokinetics (PK) in the context of a switch from an immediate release (IR) to a sustained release (SR) formulation.

PBPK & PBBM

Specific populations

Infectious Diseases

PAGE 32 (2024) Abstr 10899

Eriksson J, Sjögren E, Gillon JY, Goyal V, Satam V, Robinson S, Caplain H, Ribeiro I, Chenel M

25.06.24

A Physiologically Based Pharmacokinetic Model of Atorvastatin Acid Predicting CYP3A4 and OATP1B Drug–Drug Interactions

PBPK & PBBM

PAGE 32 (2024) Abstr 10834

Kovar C, Kanacher T, Huang F, Wu J, Sailer R, Busse D, Gómez-Mantilla JD, Ince I

25.06.24

The reference corrected VPC – A more intuitive model diagnostic

Pharmacometrics

Methodology

PAGE 32 (2024) Abstr 11053

Ibrahim MMA, Jonsson EN, Bergstrand M

1 …121314… 34

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Science & Services
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Copyright © Pharmetheus AB 2026

Whistleblower
Privacy Policy
Cookie Policy